𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An in-vitro model for tumor immunotherapy with antibody heteroconjugates

✍ Scribed by Gundram Jung; Hans J. Müller Eberhard


Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
594 KB
Volume
9
Category
Article
ISSN
0167-5699

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Expression of transgenic carcinoembryoni
✍ John A. Thompson; Anne-Marie Eades-Perner; Margarethe Ditter; William J. Muller; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 342 KB 👁 2 views

Carcinoembryonic antigen (CEA) is a tumor marker for the most common forms of adenocarcinomas. We have previously described C57BL/6 mice transgenic for the complete human CEA gene. Compared with humans, these mice reveal a conserved spatiotemporal CEA expression pattern. To establish animal models f

Depicting adoptive immunotherapy for pro
✍ Reinhard Meier; Daniel Golovko; Sidhartha Tavri; Tobias D. Henning; Christiane K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

## Abstract Genetically modified natural killer (NK) cells that recognize tumor‐associated surface antigens have recently shown promise as a novel approach for cancer immunotherapy. To determine NK cell therapy response early, a real‐time, noninvasive method to quantify NK cell homing to the tumor

An animal model for in vivo evaluation o
✍ Dr. Randall A. Hawkins; Yong Choi; Steven Scates; Sheila Rege; Carl K. Hoh; John 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

## Abstract We developed a method for evaluating tumor glycolytic rates in vivo with nude mice injected with 2‐[F‐18]fluoro‐2‐deoxy‐d‐glucose (FDG) and a dedicated animal positron emission tomography (PET) scanner. Animals were injected with NR‐6 mouse fibroblast tumor cell lines. When tumors achie

Elimination of regulatory T cells is ess
✍ Oliver M. Grauer; Roger P.M. Sutmuller; Wendy van Maren; Joannes F.M. Jacobs; Er 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 230 KB 👁 1 views

## Abstract Both melanoma and glioma cells are of neuroectodermal origin and share common tumor associated antigens. In this article, we report that the melanocyte differentiation antigen TRP2 (tyrosinase‐related protein 2) is not predominately involved in the tumor rejection of a syngeneic murine